-
Part 2 | Session 2 PRAISE-HFrEF: Glucagon-Like Peptide-1 Receptor Agonism in HFrEF and Obesity
-
Part 2 | Session 3 WICD-MI: Predicting HF Events in Pts with LV Dysfunction after AMI
-
Part 2 | Session 4 TITRATE-HF: GDMT Implementation, Prognosis and LVEF Improvement in HFrEF
-
Part 2 | Session 5 VELOCITY: Vericiguat 5mg in Pts with Heart Failure
-
Part 2 | Session 9 SCD-PROTECT: SCD in New Non-ischemic Cardiomyopathy or MI/CAD
-
Part 2 | Session 11 Liver Stiffness to Assess Central Venous Pressure in HF or Low Ejection Fraction
-
Part 2 | Session 12 Secondary Analysis of FINEARTS-HF: Effects of Finerenone on Readmissions for HF
-
Part 2 | Session 14 Kidney Function Trajectories Before and After HF Hospitalisation in HFrEF
ESC HF 25 - Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Maja Cikes (University Hospital Centre Zagreb, HR) for an insightful wrap up of the novel data concerning preventive cardiology that was presented at 2025's Heart Failure Congress.
Trials discussed include:
REDICAE (00:42)
FINEARTS HF (02:27)
CRISPR Gene Editing with Nexiguran Ziclumeran (05:53)
HELIOS B (07:12)
RESHAPE HF 2 (08:15)
FUTURE HF (09:44)
Recorded on-site at ESC HF 2025, Belgrade.
Support: This is an independent discussion produced by Radcliffe Cardiology.
Watch our video collection following the late-breaking science sessions from the ESC Heart Failure Association's 2025 congress. Our Expert Interviews provide insights on the hottest data and key take-home messages from the most influential trials.
More from this programme
Faculty Biographies

Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.
She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.
Dr Van Spall is an Editorial Board…

Maja Cikes
Associate Professor
Prof Maja Cikes is Associate Professor at University Hospital Centre Zagreb, HR. Prof Cikes has dedicated a significant portion of her career to advancing scientific knowledge in the field of cardiology. Her research interests span a wide range of topics, including cardiac imaging techniques, cardiovascular risk assessment, and the role of genetics in cardiovascular diseases.
She has authored numerous publications in prestigious medical journals, contributing to the collective understanding of cardiovascular medicine.
Comments